Exact Sciences (EXAS) Tops Q4 EPS by 7c; Offers Guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Research and development: 7.63M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 7.63M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.72), $0.07 better than the analyst estimate of ($0.79). Revenue for the quarter came in at $553 million versus the consensus estimate of $524.51 million.
GUIDANCE:
Exact Sciences sees FY2023 revenue of $2265-2315 million, versus the consensus of $2289 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
